Drug Design, Development and Therapy (Nov 2015)
Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]
Abstract
Yin Q, Li J, Xia Y, Zhang R, et al. Drug Design, Development and Therapy. 2015;9:5407–5419. On page 5410, Figure 2 was wrongly labelled as Figure 3. On page 5410, the Notes for Figure 1 should be: + indicates low risk, - indicates high risk, and ? indicates this is unclear. View original article by Yin et al.